1. Department of Medical Oncology and Hematology, CancerCare Manitoba and University of Manitoba, Winnipeg, MB, Canada;
2. Department of Medical Oncology and Hematology, Princess Margaret Cancer Centre and University of Toronto, Toronto, ON, Canada;
3. Department of Oncology, Juravinski Cancer Centre and McMaster University, Hamilton, ON, Canada;
4. Department of Hematology, Allan Blair Cancer Centre, Regina, SK, Canada;
5. University of Saskatchewan, Saskatchewan, SK, Canada;
6. Department of Pathology and Molecular Medicine, Queen’s University, Kingston, ON, Canada;
7. Research Institute of Oncology and Hematology, CancerCare Manitoba and Department of Biochemistry, University of Manitoba, Winnipeg, MB, Canada;
8. Astex Pharmaceuticals, Cambridge, UK;
9. Canadian Cancer Trials Group, Queen’s University, Kingston, ON, Canada;
10. Department of Medicine, Queen’s University, Kingston, ON, Canada